Oncoscience

2026 Press Releases

Rare Extraluminal Esophageal Cancer Invades Spine Despite Normal Endoscopy

May 14, 2026
“Esophageal tumors can rarely escape endoscopic detection by growing in atypical patterns, such as entirely outside the esophageal lumen.”BUFFALO, NY — May 14, 2026 — A new case report was published in Volume 13 of Oncoscience on March 19, 2026, titled “Unprecedented non-luminal esophageal adenocarcinoma invading the spine.”The study was led by first and corresponding author Benjamin Wenyuan Xie from the University of Louisville School of Medicine. In this report, the authors... continue reading >>

Low-Cost Color Sensor Device Enables Rapid Detection of Ovarian Cancer Biomarkers

May 7, 2026
“A sensitive nucleic acid detection approach based on tracing the inorganic phosphate (Pi) created during amplification by means of the colorimetric method has been presented.”BUFFALO, NY — May 7, 2026 — A new research paper was published in Volume 13 of Oncoscience on March 13, 2026, titled “A low-cost color sensor device for rapid detection of high-grade serous ovarian carcinoma (HGSOC).”The study was led by the first and corresponding author Faisal Iqbal from the University of... continue reading >>

Lifestyle, Diet, and Clinical Factors Shape the Gut Microbiome in Cancer Patients

April 28, 2026
“Lifestyle factors, such as physical activity and dietary modifications can beneficially modulate the gut microbiome of cancer patients, however their effects are often shaped by non-modifiable variables.”BUFFALO, NY — April 28, 2026 — A new review was published in Volume 13 of Oncoscience on March 11, 2026, titled “Associations among physical activity, diet, non-lifestyle characteristics and the gut microbiome of cancer patients: A scoping review and network analysis.”The study... continue reading >>

Deceptive Ovarian Cancer Case Mimics Pelvic Abscess, Delaying Diagnosis in Postmenopausal Woman

April 22, 2026
“Mucinous ovarian carcinoma (MOC) is a rare subtype of epithelial ovarian cancer (3–5%), typically affecting women between 20 and 40 years old.”BUFFALO, NY — April 22, 2026 — A new case report was published in Volume 13 of Oncoscience on March 11, 2026, titled “Deceptive clinical course of mucinous ovarian carcinoma mimicking pelvic abscess in a postmenopausal woman: An exceptional case report.”The study was led by first author Aparna Jarathi and corresponding author Ajay Kumar... continue reading >>

Rare Scalp Reaction Identified in Lung Cancer Patient Receiving Amivantamab After Radiotherapy

April 16, 2026
“Amivantamab, a bispecific monoclonal antibody directed against the epidermal growth factor receptor (EGFR) and mesenchymal–epithelial transition factor (MET), has demonstrated significant clinical activity and is increasingly incorporated into frontline regimens for EGFR-mutant non–small cell lung cancer (NSCLC).”BUFFALO, NY — April 16, 2026 — A new case report was published in Volume 13 of Oncoscience on March 11, 2026, titled “Erosive pustular dermatosis–like scalp... continue reading >>

COCOON Trial Shows Proactive Skin Care Can Halve Dermatologic Toxicity in EGFR-Mutant NSCLC

April 3, 2026
“Compared to standard reactive care, this strategy halved the incidence of grade ≥2 dermatologic AEs (38.6% vs. 76.5%) and reduced grade ≥3 events and treatment discontinuations.”BUFFALO, NY — April 3, 2026 — A new research perspective was published in Volume 13 of Oncoscience on March 11, 2026, titled “Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC.”Led by first and corresponding author Bishal Tiwari from the Nassau... continue reading >>

Targeting MD2 Could Limit Prostate Cancer Bone Metastasis

April 1, 2026
“Additionally, we show that soluble MD2 (sMD2) may serve as a non-invasive biomarker of metastatic burden and help predict resistance to poly ADP-ribose polymerase (PARP) inhibitor therapy.”BUFFALO, NY — April 1, 2026 — A new research perspective was published in Volume 13 of Oncoscience on March 11, 2026, titled “Targeting MD2 in prostate cancer bone metastasis: Mechanistic insights and therapeutic potential.”Led by co-first authors Melina A. Dattilo from Universidad de Buenos... continue reading >>

Surgical Management and Reconstruction Strategies Highlighted for Head and Neck Basal Cell Carcinoma

March 26, 2026
“Surgical excision remains the cornerstone of curative treatment, with recommended margins depending on tumor risk stratification.”BUFFALO, NY — March 26, 2026 — A new research perspective was published in Volume 13 of Oncoscienceon March 11, 2026, titled “Basal cell carcinoma of the head and neck: Surgical management and postoperative strategies – A researcher’s perspective.”Led by Lawik Revend from Army Hospital Berlin, with Doha Revend from the same institution and... continue reading >>

Tumor-Informed Liquid Biopsy Suggests Structural-Variant ddPCR Can Monitor High-Grade Serous Ovarian Cancer

March 19, 2026
“Our result shows the detection of SVs from pre-treatment cfDNA using tumor-informed breakpoints-spanning ddPCR is feasible and may enable a novel and sensitive method for monitoring on-treatment disease burden.”BUFFALO, NY — March 19, 2026 — A new research paper was published in Volume 13 of Oncoscience on March 5, 2026, titled “Tumor-informed liquid biopsy detection of structural variants in high grade serous ovarian cancer.”Led by Jian Li from The University of Texas M.D.... continue reading >>

Impact Journals to Participate at AACR Annual Meeting 2026 in San Diego

March 16, 2026
Conference attendees are warmly invited to visit Booth 3641 to meet members of the Impact Journals team, discover notable recent publications, and discuss opportunities for collaboration.BUFFALO, NY – March 16, 2026 – Impact Journals (publisher of Aging-US, Oncotarget, Oncoscience, and Genes & Cancer), is pleased to announce its participation as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2026. The meeting will take place April 17–22, 2026, at... continue reading >>

MYC Amplification in Metastatic Prostate Cancer Associated with Reduced Tumor Immunogenicity

March 11, 2026
“MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics files.”BUFFALO, NY — March 11, 2026 — A new research paper was published in Volume 13 of Oncoscience on February 7, 2026, titled “Reduced immunogenicity of MYC amplified, metastatic prostate cancer.”Led by Sunny Kahlon of the Department of Molecular Medicine, Morsani College of Medicine, University of South Florida — with... continue reading >>

Rare Pancreatic Tumor Case Suggests Distinctive Calcification Patterns in Solid Pseudopapillary Neoplasms

March 6, 2026
“This case underscores the diagnostic value of integrating imaging, histopathology, and immunohistochemistry.”BUFFALO, NY — March 6, 2026 — A new case report was published in Volume 13 of Oncoscienceon February 7, 2026, titled “Massive calcified solid pseudopapillary neoplasm of the pancreatic head.” Led by Faten Limaiem — who is also the corresponding author and affiliated with Hospital Mongi Slim La Marsa in La Marsa, Tunisia — and co-author Mohamed Hajri, the report... continue reading >>

Gastrointestinal Toxicity Linked to Targeted Cancer Therapies in the United States

February 20, 2026
“This review comprehensively examines the mechanisms, clinicopathological features, and management strategies of GI toxicity induced by TKIs, ADCs, and CAR-T therapies, emphasizing the diagnostic role of pathologists in identifying treatment-related injury patterns.”BUFFALO, NY — February 20, 2026 — A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled “Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic... continue reading >>

New Dual-Action Compound Reduces Pancreatic Cancer Cell Growth

February 10, 2026
“Our data demonstrates that SB-216 effectively inhibits PDAC cell growth through inhibiting oncogenic microtubules and mitochondrial function.”BUFFALO, NY — February 10, 2026 — A new research paper was published in Volume 13 of Oncoscience on January 28, 2026, titled “Dual targeting of oncogenic microtubules and mitochondria in PDAC.”In this study led by first author Michael W. Spinrad with corresponding author, Evan S. Glazer from The University of Tennessee Health Science... continue reading >>

5-FU Chemotherapy Linked to Rare Brain Toxicity in Cancer Patient

February 5, 2026
“The patient’s symptoms resolved after permanently stopping 5-FU and administering lactulose and intravenous fluids, therefore supporting the diagnosis of hyperammonemic encephalopathy due to 5-FU.”BUFFALO, NY — February 5, 2026 — A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled “Silent toxicity: A rare case of 5-fluorouracil-induced hyperammonemic encephalopathy.”In this report, Areti Kalfoutzou from the National and Kapodistrian... continue reading >>

Early Recognition and Surgical Management Key in Necrotizing Fasciitis of the Head and Neck

January 29, 2026
“Necrotizing fasciitis (NF) of the head and neck is a rare but rapidly progressive and life-threatening soft tissue infection that constitutes a true surgical emergency.”BUFFALO, NY — January 29, 2026 — A new research perspective was published in Volume 12 of Oncoscience on December 23, 2025, titled “Necrotizing fasciitis of the head and neck – clinical features, diagnostics, and management strategies.”Led by first author Anna Aydin, together with corresponding author Florian... continue reading >>

Rare Sciatic Nerve Tumor in Child Successfully Treated with Microsurgery

January 21, 2026
“This case underscores the importance of meticulous surgical technique, the potential value of IONM, and vigilant postoperative care in achieving optimal outcomes for deep-seated pediatric neurofibromas.”BUFFALO, NY — January 21, 2026 — A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled “Solitary diffuse-type giant neurofibroma arising from the sciatic nerve in a 13-year-old: A rare occurrence.”In this report by Reshmi Sultana from the All... continue reading >>